ICON (ICLR) Earnings Date & Reports

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

ICLR is expected to report earnings to rise 3.07% to $3.36 per share on October 22

Q3'25

Est.

$3.36

Q2'25

Beat

by $0.07

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.01

Q3'24

Missed

by $0.50

The last earnings report on July 23 showed earnings per share of $3.26, beating the estimate of $3.19. With 1.60M shares outstanding, the current market capitalization sits at 27.35B.

View a ticker or compare two or three

Compare

ICLR